SYNO Synovis Life Technologies, Inc. (MM)

Attorney Advertising. The law firm of Wolf Haldenstein Adler Freeman & Herz LLP is investigating possible breaches of fiduciary duty by the Board of Directors of Synovis Life Technologies, Inc. (“Synovis” or the “Company”) [NASDAQ:SYNO] arising out of the proposed acquisition of Synovis by Baxter International Inc. (“Baxter”).

On Tuesday, December 13, 2011, Baxter and Synovis announced that Baxter will acquire Synovis pursuant to an all cash offer. Under the terms of the agreement, Synovis stockholders will receive cash of $28 in exchange for each share of Synovis common stock. However, the Company may not have adequately shopped itself before entering into this transaction and, pursuant to this proposed transaction, Baxter may be underpaying for Synovis, thus unlawfully harming Synovis shareholders.

Wolf Haldenstein has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in U.S. federal and state courts. Please visit the Wolf Haldenstein website (http://www.whafh.com) for more information about the firm.

If you own Synovis common stock and you wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Gregory Nespole or Derek Behnke Wolf Haldenstein Adler Freeman & Herz LLP 270 Madison Avenue New York, New York 10016 Phone Numbers: (800) 575-0735 (212) 545-4600

Email: nespole@whafh.com

Classmember@whafh.com

 

Website: http://www.whafh.com

Attorney Advertising. Prior Results Do Not Guarantee A Similar Outcome.